Does a Diet With the Recommended Amount of Polyunsaturated Fatty Acids, Increase Their Proportion in Maternal Milk?

Summary

During pregnancy and lactation, the consumption of PUFA n-3, through the consumption of food products that contain more ALA than conventional products, could impact nutritional and non-nutritional breast milk quality (immune criteria, metabolites, hormones), and also the implantation of the intestinal microbiota of the newborn, which is involved in preservation of short term and long term health of the child.

Conditions

• Breast Feeding

Interventions

DEVICE

Dietary advice

participants will benefit of dietary device 30-minute dietary advice carried out by a doctor at the University Hospital of Rennes, in order to provide nutritional advice adapted to pregnant women.

OTHER

Consumption of Bleu-Blanc-Coeur products

consumption of Bleu-Blanc-Cœur products from the 29th week of amenorrhea to the 45th postpartum day

OTHER

No consumption of Bleu-Blanc-Coeur products

no consumption of Bleu-Blanc-Cœur products from the 29th week of amenorrhea to the 45th postpartum day. This group will receive Système U vouchers.

BIOLOGICAL

Blood sample

the fatty acid profile of the women red blood cells of the woman wil be test at the inclusion and at 21 days post-partum

OTHER

Contact

Participants of the group A will be contacted by phone,sms, mail by a technician every 15 days from 7th month of pregnancy to the 8th month of pregnancy and then every week from the 9th month of pregnancy to the 45th postpartum day (except the week of childbirth), in order to collect their consumption data of the delivered food products.

OTHER

food questionnaire

Participants will have to complete a food questionnaire at the inclusion and at 21 days post-partum

OTHER

newborn faeces sample

Newborn faeces sample will be collected at 21 Days post partum

OTHER

breast milk sample

Breast milk sample will be collected at 21 days and 45 days post partum

Sponsors & Collaborators

• Rennes University Hospital

  lead OTHER

Study Design

Allocation

RANDOMIZED

Purpose

OTHER

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2019-04-08

Primary Completion

2022-04-22

Completion

2022-04-22

Countries

• France

Study Locations